MANAGEMENT TEAM

CHIEF MEDICAL OFFICER

Prof Gemma Figtree | MBBS (Hons1),DPhil Oxford.

Professor in Medicine at the University of Sydney.
Interventional cardiologist at the RNSH.
President of the Australian Cardiovascular Alliance, and lead of global consortium CAD Frontiers
Rhodes Scholar Oxford in the field of oxidative signalling and translational cardiovascular research.
Discoveries in Gemma’s Laboratory have been published in leading journals Circulation, European Heart Journal, JACC and Circulation,
>300 publications in peer-review journals.
Principal investigator on grants (>$25 Mill) from NHMRC, the Heart Foundation, Heart Research Aust.

CHIEF SCIENTIFIC OFFICER

Dr Owen Tang | BSc (Hons), PhD.

Dr. Owen Tang is a senior post-doctoral researcher who became a member of the Figtree lab in 2014.
With a background in molecular biology, he successfully earned a PhD in renal medicine.
Dr. Tang's pioneering research primarily revolves around the early detection of cardiovascular diseases in patients.
His expertise is in the intricate field of redox biology, with a specific focus on the redox flux within red blood cells.

MANAGING DIRECTOR

Jay Hennock | BEc

Over 25 years in corporate advisory services with Citibank and then Bank of America
Co-Founder and Director of Jacanda Capital.
Co-founded Access Systems, sold to International Gaming Technology Inc.
Co-founder and CFO of Nuon Therapeutics Inc.
Founder and CEO of Bioatrix
Currently a Director of Novapep and Prokardia.

OPERATIONS MANAGER

Dr Zara Ali | BSc, PhD

Gregory Penner | MSc, PhD.

Evan Siegel | BS, MSc, PhD.

CEO and President of Ground Zero Pharmaceuticals, Inc.
Principal Regulatory Scientist & Director Regulatory Services, Quintiles, Inc.
Director/Sr. Director, Regulatory Affairs and Corporate Compliance, Syntex, Inc. and Astra Inc.
Reviewing Toxicologist, US FDA; Supervising Toxicologist, California Food and Drug Branch.